Cover image of the article: Synthesis and Cytotoxic Evaluation of 6-Amino-4-Aryl-3-Methyl- 2,4-Dihydropyrano[2,3-C]Pyrazole-Carbonitrile Derivatives Using Borax with Potential Anticancer Effects

Image Credit:J Rep Pharm Sci

Synthesis and Cytotoxic Evaluation of 6-Amino-4-Aryl-3-Methyl- 2,4-Dihydropyrano[2,3-C]Pyrazole-Carbonitrile Derivatives Using Borax with Potential Anticancer Effects

Authors

Hadi Adibi1,*, Leila Hosseinzadeh1, Sepideh Farhadi2, Farahnaz Ahmadi2
1Novel Drug Delivery Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Novel Drug Delivery Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. Email:hadibi@kums.ac.ir

Journal of Reports in Pharmaceutical Sciences:Vol. 2, issue 2; 116-124
Published online:Aug 05, 2013
Article type:Research Article
Received:Jul 10, 2013
Accepted:Jul 28, 2013
How to Cite:Adibi H, Hosseinzadeh L, Farhadi S, Ahmadi F. Synthesis and Cytotoxic Evaluation of 6-Amino-4-Aryl-3-Methyl- 2,4-Dihydropyrano[2,3-C]Pyrazole-Carbonitrile Derivatives Using Borax with Potential Anticancer Effects. J Rep Pharm Sci. 2013;2(2):e147742. doi:

Abstract

A green and efficient one-pot, four-component synthesis of 6-amino-4-aryl-3-methyl- 2,4-dihydropyrano[2,3-c]pyrazole-carbonitrile derivatives catalyzed by borax in water has been examined and described. This method has several advantages such as environmental friendliness, shorter reaction time, excellent yields, and simple workup procedure. The in vitro cytotoxic activity of the synthesized compounds was investigated against cancer cell lines (SW48, A549, KB, HepG2) in comparison with doxorubicin, a well-known anticancer drug, using MTT colorimetric assay. The synthesized compounds showed good and reasonable cytotoxicity compared with doxorubicin in some studied cell lines. The compounds 5b, 5c, 5g in KB cell line (IC50 = 8±2.217 μM, 7±2.77 μM, 7.5±1.49 μM respectively), 5f in A549 cell line (IC50 = 31.5±2.02 μM), 5g in HepG2 cell line (IC50 = 22.5±3.09 μM), 5e, and 5i in SW48 cell line (IC50 = 23±0.772 μM, 23±4.97 μM respectively) showed the best results in close to the control drug (IC50 = 6.8±0.78 μM, 6.3±0.65 μM, 5.4±0.5 μM, 4.3±0.12 μM in A549, HepG2, KB, and SW48 cell lines respectively). 

Highlights

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Dec
2019
Synthesis of 4-Phenyl-4,5-dihydropyranopyrazolone Derivatives with Activated Potassium Carbonate: Evaluation of Anticancer Activity on Cancer Cell Lines and Apoptosis Mechanism

Synthesis of 4-Phenyl-4,5-dihydropyranopyrazolone Derivatives with Activated Potassium Carbonate: Evaluation of Anticancer Activity on Cancer Cell Lines and Apoptosis Mechanism

Leila Hosseinzadeh,
Navid Mahmoudian,
Farahnaz Ahmadi,
Hadi Adibi

Hosseinzadeh L, Mahmoudian N, Ahmadi F, Adibi H. Synthesis of 4-Phenyl-4,5-dihydropyranopyrazolone Derivatives with Activated Potassium Carbonate: Evaluation of Anticancer Activity on Cancer Cell Lines and Apoptosis Mechanism. J Rep Pharm Sci. 2019;8(2):e147411. doi: https://doi.org/10.4103/jrptps.JRPTPS_82_19

31
Oct
2013
2-Amino-4-(nitroalkyl)-4H-chromene-3-carbonitriles as New Cytotoxic Agents

2-Amino-4-(nitroalkyl)-4H-chromene-3-carbonitriles as New Cytotoxic Agents

Afsaneh Zonouzi,
Roghieh Mirzazadeh,
Maliheh Safavi,
Sussan Kabudanian Ardestani,
Saeed Emami,
Alireza Foroumadi

Zonouzi A, Mirzazadeh R, Safavi M, Kabudanian Ardestani S, Emami S, et al. 2-Amino-4-(nitroalkyl)-4H-chromene-3-carbonitriles as New Cytotoxic Agents. Iran J Pharm Res. 2013;12(4):e125751. doi: https://doi.org/10.22037/ijpr.2013.1396

30
Apr
2021
Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids

Hong-Juan Liu,
Xing Huang,
Qing-Kun Shen,
Hao Deng,
Zhiyong Li,
Zhe-Shan Quan

Liu H, Huang X, Shen Q, Deng H, Li Z, et al. Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids. Iran J Pharm Res. 2021;20(2):e124321. doi: https://doi.org/10.22037/ijpr.2020.113547.14363

27
Apr
2026
Synthesis, Cytotoxicity, and Structure Activity Relationship SAR of Novel Azo Substituted Pyrazoles

Synthesis, Cytotoxicity, and Structure Activity Relationship SAR of Novel Azo Substituted Pyrazoles

Khaled Mohammed Alseud

Mohammed Alseud K. Synthesis, Cytotoxicity, and Structure Activity Relationship SAR of Novel Azo Substituted Pyrazoles. J Rep Pharm Sci. 2026;14(1):e167584. doi: https://doi.org/10.5812/jrps-167584

30
Apr
2014
N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents

N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents

Ahmad Mohammadi-Farani,
Neda Heidarian,
Alireza Aliabadi

Mohammadi-Farani A, Heidarian N, Aliabadi A. N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents. Iran J Pharm Res. 2014;13(2):e125547. doi: https://doi.org/10.22037/ijpr.2014.1503

More by these authors

Hadi AdibiPubMedScholar
Leila HosseinzadehPubMedScholar
Sepideh FarhadiPubMedScholar
Farahnaz AhmadiPubMedScholar
Share
Cited by
Metrics